Immunohistochemistry of tumor sections from CRC patients demonstrated enhanced p53 phosphorylation in tumors with low TGM2 expression, while tumors with high TGM2 showed almost no staining for S15-phosphorylation of p53 (Suppl. Here, TGM2 is linked to neoplasm.